Executive Gov
  • Home
  • Acquisition & Procurement
  • Agencies
    • DoD
    • Intelligence
    • DHS
    • Civilian
    • Space
  • Cybersecurity
  • Technology
  • Awards
  • News
  • About
  • Wash100
  • Contact Us
    • Advertising
    • Submit your news
No Result
View All Result
Executive Gov
  • Home
  • Acquisition & Procurement
  • Agencies
    • DoD
    • Intelligence
    • DHS
    • Civilian
    • Space
  • Cybersecurity
  • Technology
  • Awards
  • News
  • About
  • Wash100
  • Contact Us
    • Advertising
    • Submit your news
No Result
View All Result
Executive Gov
No Result
View All Result
Home Government Technology

Oracle Utilizes Therapeutic Learning System to Record COVID-19 Drug Effectiveness

by Sarah Sybert
December 6, 2022
in Government Technology, News
Oracle Utilizes Therapeutic Learning System to Record COVID-19 Drug Effectiveness

Oracle Utilizes Therapeutic Learning System to Record COVID-19 Drug Effectiveness

Table of Contents

  • You might also like
  • GSA Seeks Comments on Draft AI Data Safeguarding Clause
  • Kelly Hammett Named Air Force Nuclear Weapons Center Executive Director
  • DOE’s ARPA-E Unveils $72M for Critical Minerals, Magnet R&D Projects

You might also like

GSA Seeks Comments on Draft AI Data Safeguarding Clause

Kelly Hammett Named Air Force Nuclear Weapons Center Executive Director

DOE’s ARPA-E Unveils $72M for Critical Minerals, Magnet R&D Projects

Oracle has utilized its technology platform in the ongoing fight against COVID-19 to develop and deploy a series of cloud applications that will gather the data necessary to determine what drugs are effective in treating or preventing the virus, the company announced on Thursday.

The company has used a clinical trials system, which has examined many drugs including the cancer drug Keytruda, that have been approved by regulators worldwide after Oracle Clinical Trial Systems.

The system has collected data to prove drugs were both safe and effective. The Oracle Cloud has begun testing the safety and effectiveness of dozens of different COVID-19 drugs and vaccines. The trials will be completed in many countries and hundreds of institutional sites.

Oracle’s newest cloud system, Clinical One, will enable institutions to start-up a clinical trial in as few as two weeks. The company has also integrated a therapeutic learning system in addition to gathering data from COVID-19 clinical trials.

The company has built and donated to the US government a COVID-19 Therapeutic Learning System that has allowed physicians and patients to record the effectiveness of COVID-19 drug therapies, such as Hydroxychloroquine, Remdesivir and Kaletra.

The drugs have been safely used to treat other diseases but are not yet definitively proven to be effective against COVID-19. Physicians are now routinely prescribing these drugs to treat COVID-19 patients.

Oracle’s Therapeutic Learning System will enable the physician to record the patient’s daily progress. The solution will quickly discover which of the new drugs are most effective against COVID-19, optimal dosages and how early in the disease progression the drugs need to be administered.

The Therapeutic Learning System was the result of a partnership with the National Institute of Health, the Food and Drug Administration, the Center for Disease Control and Prevention, Centers for Medicare & Medicaid Services and the Department of Health and Human Services.

About Oracle  

The Oracle Cloud offers a complete suite of integrated applications for Sales, Service, Marketing, Human Resources, Finance, Supply Chain and Manufacturing, plus Highly Automated and Secure Generation 2 Infrastructure featuring the Oracle Autonomous Database.

Stay connected via Google News
Follow us for the latest travel updates and guides.
Add as preferred source on Google
Share5Tweet19

Recommended For You

GSA Seeks Comments on Draft AI Data Safeguarding Clause

by Jane Edwards
June 19, 2026
General Services Administration logo. GSA has started soliciting feedback on a draft AI data safeguarding clause.

GSA has sought feedback on a draft AI data safeguarding clauseThe proposed clause outlines requirements for LLM use in contractingThe 2026 FedCiv Summit will examine AI, cloud and...

Read moreDetails

Kelly Hammett Named Air Force Nuclear Weapons Center Executive Director

by Miles Jamison
June 19, 2026
Kelly Hammett. The Air Force Nuclear Weapons Center has appointed Kelly Hammett as executive director.

Kelly Hammett has been named executive director of the Air Force Nuclear Weapons CenterHe will advise AFNWC leadership on the acquisition, sustainment and modernization of nuclear weapons systemsHammett...

Read moreDetails

DOE’s ARPA-E Unveils $72M for Critical Minerals, Magnet R&D Projects

by Jane Edwards
June 19, 2026
Conner Prochaska. The ARPA-E director commented on selected projects to advance mineral discovery and magnets production.

DOE has announced $72 million in funding for critical minerals and magnet R&D ROCKS and MAGNITO target mineral discovery and magnet innovationSouth Dakota Mines and the University of Houston...

Read moreDetails

DIA Seeks Proposals for DORE3 Contract

by Miles Jamison
June 19, 2026
DIA logo. The Defense Intelligence Agency has issued a request for proposals for the DORE3 contract.

DIA has issued a request for proposals for the DORE3 contractThe contract covers 11 mission support areas, including collection concept development, data sciences support and program supportThe contractor...

Read moreDetails

USINDOPACOM Chief Adm. Samuel Paparo Makes Case for 2027 Budget, Cites Chinese Military Woes

by Jamie Bennet
June 19, 2026
Samuel Paparo. The USINDOPACOM Commander stressed the need for increased military preparedness against China.

U.S. Navy Adm. Samuel Paparo reportedly sent a private report to Congress detailing the needs of the Indo-Pacific Command to counter threats from ChinaUSINDOPACOM is requesting $122 billion...

Read moreDetails
Sign Up For Our Newsletter
Subscribe to our mailing list to receives daily updates direct to your inbox!
Invalid email address
Your privacy is guranteed.
Thanks for subscribing!

Sponsors

About ExecutiveGov

ExecutiveGov, published by Executive Mosaic, is a site dedicated to the news and headlines in the federal government. ExecutiveGov serves as a news source for the hot topics and issues facing federal government departments and agencies such as Gov 2.0, cybersecurity policy, health IT, green IT and national security. We also aim to spotlight various federal government employees and interview key government executives whose impact resonates beyond their agency.

CATEGORIES

  • Acquisition & Procurement
  • Announcements
  • Articles
  • Artificial Intelligence
  • Awards
  • Big Data & Analytics News
  • C4ISR
  • Civilian
  • Cloud
  • Contract Awards
  • Cybersecurity
  • Defense And Intelligence
  • Defense Security Cooperation
  • DHS
  • Digital Assets
  • Digital Modernization
  • DoD
  • Events
  • Executive Moves
  • Executive Spotlights
  • Federal Civilian
  • Financial Reports
  • Foreign Military Sales
  • General News
  • GovCon Expert
  • Government Technology
  • GSA
  • Healthcare IT
  • Industry News
  • Intelligence
  • Legislation
  • M&A Activity
  • National Security
  • News
  • Policy Updates
  • Press Releases
  • Profiles
  • Space
  • Videos
  • Wash100
Sign Up For Our Newsletter
Subscribe to our mailing list to receives daily updates direct to your inbox!
Invalid email address
Your privacy is guranteed.
Thanks for subscribing!

Copyright 2026 Executive Mosaic. All Rights Reserved.

No Result
View All Result
  • Home
  • Acquisition & Procurement
  • Agencies
    • DoD
    • Intelligence
    • DHS
    • Civilian
    • Space
  • Cybersecurity
  • Technology
  • Awards
  • News
  • About
  • Wash100
  • Contact Us
    • Advertising
    • Submit your news

Copyright 2026 Executive Mosaic. All Rights Reserved.

Get your free GovCon news!

Get your latest GovCon news and insights. Become a VIP and subscribe to the GovConWire Daily News.

Invalid email address
We promise not to spam you. You can unsubscribe at any time.
Thanks for subscribing!